Lindbrook Capital’s Avanos Medical AVNS Stock Holding History

Lindbrook Capital’s Portfolio AVNS Stock Details AVNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	$516	Buy	36 +8	+29%	+$125	﹤0.01%	2615
2024 Q4	$446	Buy	28 +2	+8%	+$40	﹤0.01%	2649
2024 Q3	$625	Hold	26	–	–	﹤0.01%	2610
2024 Q2	$518	Buy	+26	New	+$506	﹤0.01%	2592
2023 Q4	–	Sell	-93	Closed	-$1.88K	–	2700
2023 Q3	$1.88K	Sell	93 -12	-11%	-$272	﹤0.01%	2154
2023 Q2	$2.68K	Buy	105 +12	+13%	+$316	﹤0.01%	2035
2023 Q1	$2.77K	Sell	93 -37	-28%	-$1.07K	﹤0.01%	2103
2022 Q4	$3.52K	Sell	130 -40	-24%	-$978	﹤0.01%	1984
2022 Q3	$4K	Hold	170	–	–	﹤0.01%	1732
2022 Q2	$5K	Sell	170 -10	-6%	-$287	﹤0.01%	1523
2022 Q1	$6K	Buy	180 +50	+38%	+$1.61K	﹤0.01%	1495
2021 Q4	$5K	Buy	+130	New	+$4.2K	﹤0.01%	1488

Other funds holding AVNS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Lindbrook Capital's AVNS Position: Q1 2025 in Review

Lindbrook Capital increased its Avanos Medical (AVNS) stake by 29% in Q1 2025, buying an estimated $125 and bringing the position to 36 shares worth $516. The position accounts for ﹤0.01% of the portfolio, ranked #2615.

Lindbrook Capital first reported a position in AVNS in Q4 2021 and has held it in 12 quarters since. The position peaked at $6K in Q1 2022. 277 funds tracked by Wall St. Rank hold AVNS as of Q1 2025.

Lindbrook Capital held 36 shares of Avanos Medical worth $516 as of Q1 2025.
Lindbrook Capital bought 8 Avanos Medical shares in Q1 2025, an estimated $125.
Avanos Medical made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #2615 holding.
Lindbrook Capital first reported a position in Avanos Medical in Q4 2021 and has held it in 12 quarters since.
Lindbrook Capital's Avanos Medical position peaked at $6K in Q1 2022.
277 funds tracked by Wall St. Rank held Avanos Medical as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.